Gender bias in FDA premarket approval of cardiovascular devices

A systematic review of high-risk cardiovascular devices receiving premarket approval from the U.S. Food and Drug Administration (FDA) found that women were under-represented in the evidence presented to the FDA.  Read more at

Related Articles:

Leave a Reply

You have to agree to the comment policy.


Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing